Institution
University of Chicago Medical Center
Also known as: UChicago Medical Center · UChicago Medicine · UCMC
- 228running trials
- 70closed trials
- 17,660publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Study of LY4336619 in Adult Participants With Advanced Solid Tumors
Not yet recruiting
Recruiting
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Recruiting
Recruiting
Recruiting
A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
Recruiting
Impact of Barostimulation on Hemodynamics in Adults With Heart Failure
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
Recruiting
Recruiting
Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Recruiting
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Recruiting
Recruiting
Showing 50 of 228.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer18 recruiting
- Ovarian cancer16 recruiting
- Colorectal cancer10 recruiting
- Bladder cancer9 recruiting
- Gastric and oesophageal cancer8 recruiting
- Head and neck cancer8 recruiting
- Liver and biliary tract cancer7 recruiting
- Stroke7 recruiting
- Childhood cancers6 recruiting
- Endometrial cancer6 recruiting
- Multiple myeloma6 recruiting
- Pancreatic cancer6 recruiting
- Prostate cancer6 recruiting
- Melanoma5 recruiting
- Metastatic breast cancer5 recruiting
- Triple-negative breast cancer5 recruiting
- High blood pressure4 recruiting
- Mantle cell lymphoma4 recruiting
- Mesothelioma4 recruiting
- Systemic sclerosis (scleroderma)4 recruiting
- Type 1 diabetes4 recruiting
- Acute lymphoblastic leukaemia3 recruiting
- COPD3 recruiting
- Dermatomyositis and polymyositis (myositis)3 recruiting
- Diffuse large B-cell lymphoma3 recruiting
- Heart failure3 recruiting
- Pulmonary arterial hypertension3 recruiting
- Type 2 diabetes3 recruiting
- Ulcerative colitis3 recruiting
- Acute myeloid leukaemia2 recruiting
- Atrial fibrillation2 recruiting
- Cervical cancer2 recruiting
- Chronic lymphocytic leukaemia2 recruiting
- Crohn's disease2 recruiting
- Follicular lymphoma2 recruiting
- Liver cirrhosis2 recruiting
- Lupus (SLE)2 recruiting
- Multiple sclerosis2 recruiting
- Parkinson disease2 recruiting
- ALS (motor neurone disease)1 recruiting
- Amyloidosis1 recruiting
- Aortic stenosis1 recruiting
- Bipolar disorder1 recruiting
- Chronic kidney disease1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Coeliac disease1 recruiting
- Coronary artery disease1 recruiting
- Depression1 recruiting
- Diabetic neuropathy1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hepatitis C1 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
- Mild cognitive impairment1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Neuroendocrine tumours1 recruiting
- Obesity1 recruiting
- Osteoarthritis1 recruiting
- Peripheral artery disease1 recruiting
- Primary biliary cholangitis1 recruiting
- Psoriasis1 recruiting
- Psoriatic arthritis1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Schizophrenia1 recruiting
- Testicular cancer1 recruiting
- Thymoma and thymic carcinoma1 recruiting
- Vascular dementia1 recruiting
Closed trials
Completed
A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder
Completed
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB
Completed
Recruiting
Recruiting
Terminated
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
Recruiting
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Completed
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Completed
Completed
Completed
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
Completed
Terminated
Phase 1/2 Study of ISB 1442 in Relapsed/Refractory Multiple Myeloma
Terminated
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Terminated
Completed
Completed
Completed
Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma
Completed
Terminated
Terminated
Completed
Completed
Terminated
Completed
Completed
COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.
Completed
Recruiting
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Completed
TTX-030 in Combination With Immunotherapy and/or Chemotherapy in Subjects With Advanced Cancers
Completed
Terminated
Completed
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
Completed
Completed
Completed
Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia
Completed
Completed
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
Completed
Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy
Completed
Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors
Completed
Recruiting
Showing 50 of 70.
Registry name variants (79)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
University of Chicago Medical Center
Chicago, Illinois 60637
171 trials
The University of Chicago Medical Center
Chicago, Illinois 60637
38 trials
The University of Chicago Medical Center (UCMC)
Chicago, Illinois 60637
11 trials
UChicago Medicine - River East
Chicago, Illinois 60611
6 trials
The University of Chicago Medical Center - Duchossois Center for Advanced Medicine
Chicago, Illinois 60637
3 trials
Contact: Qinhan Chen
NCT06290934Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
The University of Chicago Medical Center - Hyde Park - Hematology & Oncology
Chicago, Illinois 60637
3 trials
UChicago Medicine
Chicago, Illinois 60637
3 trials
NCT07053436Horizon Two: HR NDMM (MMRC-100)
Contact: Joanna Pagacz
NCT04294927TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
Contact: Kathryn Mills
NCT03944798Surveillance AFter Extremity Tumor surgerY
The University of Chicago Medical Center - Oncology
Chicago, Illinois 60637
2 trials
Contact: Principal Investigator
The University of Chicago Medical Center (UCMC) Duchossois Center for Advanced Medicine (DCAM)
Chicago, Illinois 60637
2 trials
UChicago Medicine - Duchossois Center for Advanced Medicine - Nephrology
Chicago, Illinois 60637
2 trials
The University of Chicago Medical Center - Accepting Adult and Adolescent Patients
Chicago, Illinois 60637
1 trial
Contact: Dr. Cuoghi Edens, MD, FAAP
The University of Chicago Medical Center - Accepting Adult and Juvenile Patients
Chicago, Illinois 60637
1 trial
Contact: Dr. Iazsmin Ventura, MD (principal investigator)
The University of Chicago Medical Center, CCD - Investigational Drug Service Pharmacy
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center
Chicago, Illinois 60637-1443
1 trial
The University of Chicago Medical Center, Investigational Drug Service Department of Pharmacy
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center - Neurology
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center (Site 0004)
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center (Site 0007)
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center (Site 0047)
Chicago, Illinois 60637-1447
1 trial
The University of Chicago Medical Center (Site 0118)
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Center (Site 1539)
Chicago, Illinois 60637
1 trial
The University of Chicago Medical Centre
Chicago, Illinois 60637
1 trial
Univ Chicago Medical Center
Chicago, Illinois
1 trial
University of Chicago Medical Center, Biological Science Division
Chicago, Illinois 60637
1 trial
NCT07713849Transition Care for FEP
Contact: Madeline Perez Lab Manager, B.S
University of Chicago Medical Center, CCD
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center - Duchossis Center for Advanced Medicine
Chicago, Illinois 60637-1426
1 trial
University of Chicago Medical Center - Duchossois Center for Advanced Medicine (Adults only)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0045)
Chicago, Illinois 60637
1 trial
NCT06136624Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Contact: Study Coordinator
University of Chicago Medical Center (Site 0067)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0109)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0120)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0126)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0134)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0136)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0145)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 0207)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 1007)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 1037)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 2828)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 4037)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 5002)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 5037)
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center (Site 5066)
Chicago, Illinois 60637
1 trial
Contact: Study Coordinator
University of Chicago Medical Center- Site Number : 8400017
Chicago, Illinois 60637
1 trial
NCT06481904Registry for Stage 2 Type 1 Diabetes
University of Chicago Medical Center- Site Number : 8400018
Chicago, Illinois 60637
1 trial
University of Chicago Medical Center- Site Number : 8400055
Chicago, Illinois 60637
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Ulcerative colitis59 works · 10 trials
- Crohn's disease44 works · 5 trials
Institution data: ROR 0076kfe04 (CC0-1.0)Updated 15 Nov 2026